OAC
IMDX

OMERS Administration Corp’s Insight Molecular Diagnostics IMDX Stock Holding History

OMERS Administration Corp’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,500
Closed -$34.4K – 1071
2026
Q1 		$34.4K Sell
10,500
-15,664
-60% -$90.9K ﹤0.01% 1071
2025
Q4 		$196K Buy
+26,164
New +$148K ﹤0.01% 915

Other funds holding IMDX

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
FOR
Family Office Research Bethesda, Maryland $267M AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

OMERS Administration Corp's IMDX Position: Q2 2026 in Review

OMERS Administration Corp sold out of Insight Molecular Diagnostics (IMDX) in Q2 2026, closing a stake of 10,500 shares — an estimated $34.4K sold.

OMERS Administration Corp first reported a position in IMDX in Q4 2025 and held it in 2 quarters. The position peaked at $196K in Q4 2025. 40 funds tracked by Wall St. Rank hold IMDX as of Q2 2026.

  • OMERS Administration Corp reported no remaining Insight Molecular Diagnostics position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 10,500 Insight Molecular Diagnostics shares in Q2 2026, an estimated $34.4K.
  • OMERS Administration Corp first reported a position in Insight Molecular Diagnostics in Q4 2025 and held it in 2 quarters.
  • OMERS Administration Corp's Insight Molecular Diagnostics position peaked at $196K in Q4 2025.
  • 40 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.